{
  "meta": {
    "title": "00280_Mid_Day_Module_Medicine-1",
    "url": "https://brainandscalpel.vercel.app/00280-mid-day-module-medicine-1-bb53ae4b.html",
    "scrapedAt": "2025-11-29T18:15:03.201Z"
  },
  "questions": [
    {
      "id": 49633,
      "choices": [
        {
          "id": 198095,
          "text": "<p>The second intercostal space on the right side</p>"
        },
        {
          "id": 198096,
          "text": "<p>The second intercostal space on the left side</p>"
        },
        {
          "id": 198097,
          "text": "<p>The third intercostal space on the right side</p>"
        },
        {
          "id": 198098,
          "text": "<p>The third intercostal space on the left side</p>"
        }
      ],
      "text": "<p>In the context of cardiac examination, Erb's point corresponds to which of the following locations? (NEET PG 2015)</p>",
      "unique_key": "Q9229847",
      "question_audio": null,
      "question_video": null,
      "map_id": 34965200,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Correct Answer: D. The third intercostal space on the left side.</strong></p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>Erb's point is anatomically located at the third intercostal space on the left side of the sternum. This is an important auscultatory area during cardiac examination as multiple murmurs may be heard at this location. The third left intercostal space is a significant area where sounds from different cardiac structures converge, making it a crucial point for clinical examination of the heart.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A. The second intercostal space on the right side</strong>: This is the aortic area of cardiac auscultation where aortic valve sounds and murmurs related to the aortic valve are best heard. It is not Erb's point.</p><p>&nbsp;</p><p><strong>Option B. The second intercostal space on the left side</strong>: This is the pulmonic area where pulmonic valve sounds and murmurs associated with the pulmonary valve are best heard. This is not Erb's point.</p><p>&nbsp;</p><p><strong>Option C. The third intercostal space on the right side</strong>: This is not a standard auscultatory area for cardiac examination. Erb's point is specifically on the left side, not the right.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p>Erb's point is located at the third intercostal space on the left side of the sternum and serves as an important auscultatory area where multiple cardiac murmurs may be detected during examination.</p>",
      "correct_choice_id": 198098,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11740,
      "choices": [
        {
          "id": 46926,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic respiratory acidosis, acute metabolic alkalosis</span></span></span></span></p>"
        },
        {
          "id": 46927,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute respiratory acidosis, acute respiratory alkalosis</span></span></span></span></p>"
        },
        {
          "id": 46928,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute Metabolic alkalosis, acute respiratory acidosis</span></span></span></span></p>"
        },
        {
          "id": 46929,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute respiratory acidosis, acute metabolic alkalosis</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the areas marked F, C in the following diagram: (INICET NOV 2020)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/nm124.jpg\" style=\"height:306px; width:300px\" /></span></span></span></span></p>",
      "unique_key": "Q1505377",
      "question_audio": null,
      "question_video": null,
      "map_id": 34965199,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></span></strong><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute respiratory acidosis, acute respiratory alkalosis</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Area F</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Positioned in the lower left part of the diagram, which corresponds to higher PCO2 and a pH less than 7.35. This area represents <strong>Acute Respiratory Acidosis</strong> due to an increase in CO2, causing a drop in blood pH.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Area C</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Positioned in the upper right part of the diagram, which corresponds to lower PCO2 and a pH greater than 7.45. This area represents <strong>Acute Respiratory Alkalosis</strong> caused by a decrease in CO2, increasing blood pH.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/nm125.jpg\" style=\"height:507px; width:496px\" /></span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Understanding the relationship between pH, bicarbonate (HCO3-), and CO2 is crucial for interpreting arterial blood gases. Area F indicates acute respiratory acidosis due to increased CO2, and area C indicates acute respiratory alkalosis due to decreased CO2.</span></span></span></span></p>",
      "correct_choice_id": 46927,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50952,
      "choices": [
        {
          "id": 203349,
          "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lifestyle modification and weight loss&nbsp; </span></span></span></span></p>"
        },
        {
          "id": 203350,
          "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ursodeoxycholic acid and lifestyle modification&nbsp; </span></span></span></span></p>"
        },
        {
          "id": 203351,
          "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lifestyle modifications and vitamin E&nbsp; </span></span></span></span></p>"
        },
        {
          "id": 203352,
          "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pioglitazone and lifestyle modifications&nbsp;</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with a history of consumption of 2-3 drinks per week comes with complaints of right upper quadrant discomfort. He has grade 2 steatosis. His BMI was 29 kg/m&sup2; and AST and ALT levels were slightly elevated. What would you advise him?&nbsp;</span></span>(INICET Nov 2023)</p>",
      "unique_key": "Q5694344",
      "question_audio": null,
      "question_video": null,
      "map_id": 34965193,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lifestyle modification and weight loss</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation: &nbsp;</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient is likely suffering from non-alcoholic fatty liver disease (NAFLD), specifically non-alcoholic steatohepatitis (NASH), given his history of minimal alcohol consumption, grade 2 steatosis, elevated BMI, and mildly elevated liver enzymes (AST and ALT). The cornerstone of treatment for NASH is lifestyle modification and weight loss. These interventions help reduce liver fat, inflammation, and fibrosis. No FDA-approved medications currently exist for the treatment of NASH; thus, lifestyle changes are the primary recommended approach.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Ursodeoxycholic acid and lifestyle modification:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ursodeoxycholic acid is used for primary biliary cholangitis, not NASH, and thus is not appropriate here.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">&nbsp; </span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Lifestyle modifications and vitamin E:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vitamin E can be used off-label in non-diabetic patients with NASH but is not FDA-approved or considered first-line treatment. It can be considered but is secondary to lifestyle changes.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">&nbsp; </span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Pioglitazone and lifestyle modifications:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pioglitazone, along with other medications like metformin and GLP-1 receptor agonists, is sometimes used off-label for diabetic patients with NASH. However, it is not FDA-approved for NASH and should not be the first-line recommendation.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lifestyle modification and weight loss are the primary and most effective treatments for non-alcoholic steatohepatitis (NASH), as no FDA-approved medications are currently available for this condition.</span></span></span></span></p>",
      "correct_choice_id": 203349,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16290,
      "choices": [
        {
          "id": 65120,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Valacyclovir</span></span></span></p>"
        },
        {
          "id": 65121,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acyclovir</span></span></span></p>"
        },
        {
          "id": 65122,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Gancyclovir</span></span></span></p>"
        },
        {
          "id": 65123,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Foscarnet</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 54-year-old man was brought to the casualty with fever, headache, and focal seizures. EEG shows focal temporal lobe spikes. CSF sample analysis shows 50 cells with 90% Lymphocytes and 10% Neutrophils. What would be the drug of choice for this condition?&nbsp;(FMGE DEC 2021)</span></span></span></p>",
      "unique_key": "Q5830059",
      "question_audio": null,
      "question_video": null,
      "map_id": 34965309,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Acyclovir</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The clinical presentation and CSF findings suggest <strong>herpes simplex virus (HSV) encephalitis,</strong> which commonly affects the temporal lobe and shows lymphocytic pleocytosis </span><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">And EEG is showing the characteristic finding that temporal lobe epileptiform spikes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">DOC - IV Acyclovir</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Standard Dose</span></strong><span style=\"font-size:12.0pt\">: 10 to 15 mg per kilogram, administered three times a day.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Monitoring</span></strong><span style=\"font-size:12.0pt\">:</span></span></span></li>\r\n</ul>\r\n\r\n<ul style=\"list-style-type:circle; margin-left:40px\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Renal Function</span></strong><span style=\"font-size:12.0pt\">: Acyclovir can crystallize in the urine, potentially causing acute kidney injury (AKI) &ndash; needle shaped crystal</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Hydration</span></strong><span style=\"font-size:12.0pt\">: Ensure the patient is adequately hydrated to help prevent crystallization.</span></span></span></li>\r\n</ul>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Precautions</span></strong><span style=\"font-size:12.0pt\">: Monitor renal function closely, especially when using high doses in the context of herpes simplex virus encephalitis.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Note &ndash; </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Herpes simplex virus (HSV) encephalitis&nbsp;</span></strong><span style=\"font-size:12.0pt\">can occur at any age and during any season</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">MRI Findings</span></strong><span style=\"font-size:12.0pt\">: Temporal lobe hyperintensity, particularly on the medial side of the temporal lobe.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Clinical Presentation</span></strong><span style=\"font-size:12.0pt\">: Patients often present with focal seizures or behavioral abnormalities due to temporal lobe involvement.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Valacyclovir</span></strong><span style=\"font-size:12.0pt\">: An oral prodrug of acyclovir, not preferred for initial severe cases requiring intravenous treatment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Gancyclovir</span></strong><span style=\"font-size:12.0pt\">: Used for cytomegalovirus (CMV) infections, not HSV.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Foscarnet</span></strong><span style=\"font-size:12.0pt\">: Reserved for resistant HSV or CMV infections.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acyclovir is the treatment of choice for HSV encephalitis.</span></span></span></p>",
      "correct_choice_id": 65121,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11809,
      "choices": [
        {
          "id": 47202,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4, and 5</span></p>"
        },
        {
          "id": 47203,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3, 5 only</span></p>"
        },
        {
          "id": 47204,
          "text": "<p><span style=\"font-size:12.0pt;\">3, 4, 5 only</span></p>"
        },
        {
          "id": 47205,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3, 4, and 5 only</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old female patient came to the outpatient department with complaints of neck swelling. She gives a history of weight loss and palpitations. On examination, she has exophthalmos and a diffusely enlarged thyroid gland. What are the essential investigations that should be done for the patient? (INICET NOV 2021)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Thyroid scan</span></li><li><span style=\"font-size:12.0pt;\">Fine needle aspiration cytology (FNAC)</span></li><li><span style=\"font-size:12.0pt;\">Thyroid function tests</span></li><li><span style=\"font-size:12.0pt;\">Ultrasound of neck</span></li><li><span style=\"font-size:12.0pt;\">Anti-thyroid antibody</span></li></ol>",
      "unique_key": "Q5537454",
      "question_audio": null,
      "question_video": null,
      "map_id": 34965197,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) 1, 3, 4, and 5 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical presentation of neck swelling, weight loss, palpitations, exophthalmos, and a diffusely enlarged thyroid gland suggests hyperthyroidism, likely Graves' disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">FNAC is not recommended in this case because it does not provide additional diagnostic yield for Graves' disease, does not alter the treatment plan, and carries a risk of complications due to the gland's increased vascularity in Graves' disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The following investigations are essential:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">1<strong>. Thyroid scan</strong>: A radioactive iodine uptake scan helps differentiate between diffuse uptake (indicative of Graves' disease) and nodular uptake (indicative of toxic multinodular goiter or Plummer's disease).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">3.<strong> Thyroid function tests</strong>: These are crucial as they provide information on the levels of thyroid hormones (T3, T4) and thyroid-stimulating hormone (TSH), helping confirm the diagnosis of hyperthyroidism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">4<strong>. Ultrasound of neck</strong>: This imaging modality helps assess the thyroid gland's structure and can reveal increased vascularity, which is characteristic of Graves' disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">5. <strong>Anti-thyroid antibody</strong>: Testing for antibodies, such as TSH receptor antibodies (TRAbs) or thyroid-stimulating immunoglobulins (TSI), is important for diagnosing autoimmune thyroid diseases like Graves' disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For a patient with clinical signs of hyperthyroidism and a diffusely enlarged thyroid gland, essential investigations include a thyroid scan, thyroid function tests, ultrasound of the neck, and anti-thyroid antibody tests. Fine needle aspiration cytology (FNAC) is not typically required in these cases.</span></p>",
      "correct_choice_id": 47205,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11202,
      "choices": [
        {
          "id": 44774,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&gt; 50 ug/L</span></span></p>"
        },
        {
          "id": 44775,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&gt; 100 ug/L</span></span></p>"
        },
        {
          "id": 44776,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&gt; 150 ug/L</span></span></p>"
        },
        {
          "id": 44777,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&gt; 200 ug/L</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What levels of prolactin are definitely suggestive of prolactinoma? (NEET PG 2018)</span></span></p>",
      "unique_key": "Q3927676",
      "question_audio": null,
      "question_video": null,
      "map_id": 34965203,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. &gt; 200 ug/L</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prolactin levels greater than 200 ug/L are definitely suggestive of a prolactinoma. This level typically indicates the presence of a prolactin-secreting pituitary adenoma. The significant elevation in prolactin can cause clinical symptoms such as galactorrhea and amenorrhea in women, or hypogonadism in men. The diagnosis is further supported by imaging studies such as MRI, which can visualize the adenoma.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Additional Information</span></span></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/22/screenshot-2024-07-22-163238.jpg\" style=\"height:484px; width:1000px\" /></span></span></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/22/screenshot-2024-07-22-163300.jpg\" style=\"height:402px; width:1000px\" /></p>",
      "correct_choice_id": 44777,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55347,
      "choices": [
        {
          "id": 220849,
          "text": "<p><span style=\"font-size:12pt;\">Troponin</span></p>"
        },
        {
          "id": 220850,
          "text": "<p><span style=\"font-size:12pt;\">Ischemia modified albumin</span></p>"
        },
        {
          "id": 220851,
          "text": "<p><span style=\"font-size:12pt;\">LDH</span></p>"
        },
        {
          "id": 220852,
          "text": "<p><span style=\"font-size:12pt;\">CK MB</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following is earliest to rise in myocardial infarction? (FMGE JULY 2024)</span></p>",
      "unique_key": "Q5319851",
      "question_audio": null,
      "question_video": null,
      "map_id": 34965188,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Ischemia modified albumin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In the event of a myocardial infarction, certain biomarkers are released into the bloodstream as a result of cardiac muscle injury.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Among the <strong>three early markers of myocardial injury</strong>, three are particularly significant: <strong>myoglobin, heart-type fatty acid binding protein (HFABP), and ischemia modified albumin (IMA).</strong> Of these three, ischemia modified albumin is the earliest to rise and also the earliest to fall in response to myocardial ischemia. This rapid change makes it a valuable early diagnostic marker for detecting myocardial infarction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Troponin:</strong> Troponins are highly specific markers for myocardial injury and are considered the gold standard for diagnosing myocardial infarction. However, they do not rise as early as ischemia modified albumin. Typically, troponin levels start to rise 4-6 hours after the onset of myocardial infarction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. LDH (Lactate Dehydrogenase):</strong> LDH is an enzyme found in almost all body tissues and is not specific to cardiac tissue. It is a later marker of myocardial infarction, usually rising within 24-48 hours after the onset of symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. CK MB (Creatine Kinase-MB):</strong> CK-MB is a specific isoenzyme found in heart muscle and is used as a marker for myocardial infarction. However, it does not rise as early as ischemia modified albumin. CK-MB levels typically start to increase 3-6 hours after myocardial infarction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Ischemia modified albumin is the earliest biomarker to rise in the event of a myocardial infarction, making it a crucial early indicator for diagnosis.</span></p>",
      "correct_choice_id": 220850,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11972,
      "choices": [
        {
          "id": 47853,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3</span></p>"
        },
        {
          "id": 47854,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 4</span></p>"
        },
        {
          "id": 47855,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3, 4</span></p>"
        },
        {
          "id": 47856,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following types of headaches requires further evaluation? (INICET NOV 2022)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Headache for &gt; 4 hours</span></li><li><span style=\"font-size:12.0pt;\">Worst headache of life</span></li><li><span style=\"font-size:12.0pt;\">New-onset progressive headache</span></li><li><span style=\"font-size:12.0pt;\">Headache with blurring of vision</span></li></ol>",
      "unique_key": "Q6718845",
      "question_audio": null,
      "question_video": null,
      "map_id": 34965195,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. &nbsp;C) 2, 3, 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Certain types of headaches can be indicative of serious underlying conditions and thus require further evaluation to rule out life-threatening or severe pathologies:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2. Worst headache of life:</strong> This is a classic description of a subarachnoid hemorrhage, which is a medical emergency. Patients experiencing this type of headache require immediate medical attention and thorough investigation, typically involving neuroimaging.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>3. New-onset progressive headache:</strong> Progressive headaches, especially those that are new in onset and occur in adults, raise concern for potential serious conditions such as brain tumors or other intracranial pathologies. These headaches warrant detailed medical evaluation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4. Headache with blurring of vision:</strong> This symptom combination suggests possible increased intracranial pressure, which can be associated with conditions like papilledema or optic neuritis. Such cases need prompt assessment to determine the cause and appropriate management.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. Headache for &gt; 4 hours:</strong> While a headache lasting more than four hours can be distressing, it is not necessarily indicative of a severe underlying condition. Such headaches could be primary headaches like tension-type headaches or migraines, which often do not require immediate further evaluation unless they have other alarming features.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Headaches described as the \"worst headache of life,\" new-onset progressive headaches, and headaches accompanied by blurring of vision require further medical evaluation to rule out serious conditions.</span></p>",
      "correct_choice_id": 47855,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16341,
      "choices": [
        {
          "id": 65324,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Squamous cell carcinoma</span></span></p>"
        },
        {
          "id": 65325,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adenocarcinoma</span></span></p>"
        },
        {
          "id": 65326,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Large cell carcinoma</span></span></p>"
        },
        {
          "id": 65327,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Merkel cell carcinoma</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A male patient with a history of chronic smoking presents with the complaint of dysphagia. Out of the following, which type of lung cancer is most likely to be found in this patient? (FMGE JUNE 2022)</span></span></span></p>",
      "unique_key": "Q5908997",
      "question_audio": null,
      "question_video": null,
      "map_id": 34965310,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>A) Squamous cell carcinoma</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Squamous cell carcinoma of the lung is strongly associated with smoking. It can produce paraneoplastic syndromes, such as hypercalcemia due to PTH-related peptide secretion, and often presents with cavitating lung lesions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Adenocarcinoma:</span></strong><span style=\"font-size:12.0pt\"> More commonly seen in non-smokers and peripherally located in the lungs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Large cell carcinoma:</span></strong><span style=\"font-size:12.0pt\"> Less common and not as strongly associated with smoking.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Merkel cell carcinoma:</span></strong><span style=\"font-size:12.0pt\"> A rare skin cancer not associated with lung cancer or smoking.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Squamous cell carcinoma of the lung is strongly linked to smoking and may present with hypercalcemia and cavitating lung lesions.</span></span></span></p>",
      "correct_choice_id": 65324,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54258,
      "choices": [
        {
          "id": 216501,
          "text": "<p><span style=\"font-size:12.0pt;\">Pulsus Paradoxus is usually seen</span></p>"
        },
        {
          "id": 216502,
          "text": "<p><span style=\"font-size:12.0pt;\">Pericardiocentesis may be required</span></p>"
        },
        {
          "id": 216503,
          "text": "<p><span style=\"font-size:12.0pt;\">Loud S1 is a common finding</span></p>"
        },
        {
          "id": 216504,
          "text": "<p><span style=\"font-size:12.0pt;\">Echo will show diastolic RA/RV collapse</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old female with a history of chest pain and upper respiratory tract infection, seven days ago, presents with shortness of breath. She has BP of 100/60 mm Hg and a pulse rate of 110/min. Chest x-ray reviews an enlarged heart, which appears like a water bottle. Which of the following is incorrect?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q5137273",
      "question_audio": null,
      "question_video": null,
      "map_id": 34965192,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>C) Loud S1 is a common finding</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient is likely suffering from <strong>pericardial effusion</strong>, possibly progressing to cardiac tamponade, secondary to a recent viral infection. This is suggested by the history of an upper respiratory tract infection, the physical findings, and the characteristic \"water bottle\" appearance of the heart on the chest x-ray.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The incorrect statement is <strong>Loud S1 is a common finding</strong>. In fact, one of the hallmarks of cardiac tamponade is <strong>muffled or distant heart sounds</strong> due to the insulating effect of the pericardial fluid, as described in Beck's triad, which includes hypotension, jugular venous distension, and muffled heart sounds.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Pulsus Paradoxus is usually seen:</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">This is true. Pulsus paradoxus is a significant drop in blood pressure during inspiration, common in cardiac tamponade.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Pericardiocentesis may be required:</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">This is true. Pericardiocentesis is often necessary to remove the excess fluid and relieve pressure on the heart, especially if the patient is hemodynamically unstable.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Echo will show diastolic RA/RV collapse:</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">This is true. In cardiac tamponade, the pressure from the pericardial fluid prevents the right atrium and right ventricle from expanding during diastole, leading to their collapse.</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Echocardiography will reveal this diastolic collapse, confirming cardiac tamponade.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In cardiac tamponade, muffled heart sounds are a key finding, not a loud S1.</span></p>",
      "correct_choice_id": 216503,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11246,
      "choices": [
        {
          "id": 44950,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IV immunoglobulins</span></span></span></span></p>"
        },
        {
          "id": 44951,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Steroids</span></span></span></span></p>"
        },
        {
          "id": 44952,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Splenectomy</span></span></p>"
        },
        {
          "id": 44953,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Blood transfusion</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the best treatment for idiopathic thrombocytic purpura? (NEET PG 2019)</span></span></p>",
      "unique_key": "Q7790833",
      "question_audio": null,
      "question_video": null,
      "map_id": 34965204,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Splenectomy</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Splenectomy is considered the best long-term treatment option for patients with chronic ITP who do not respond to medical therapies such as steroids or immunoglobulins. The procedure involves removing the spleen, which is a site of platelet destruction in ITP. Removing the spleen often results in a permanent increase in platelet count, though it is typically reserved for patients who are refractory to first-line treatments.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Approach to ITP:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If severe ITP @ presentation: <strong>Transfusion+ steroids</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Intracranial/GI Bleed</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PC &lt; 5k</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Large oral bleed/Retinal bleed</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Low dose steroids recommended in all cases of ITP.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If steroid unresponsive, decision depends on duration:</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Persistent (3-12 months):&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rituximab vs TPO-RA (Romiplostim (S. C.), Eltrombopag (Oral) </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>(&gt;12 months):</strong> Rituximab vs Splenectomy vs TPO-RA</span></span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If still persistent/refractory, possible options are:</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fostamatinib:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SyK (Tyrosine kinase inhibitor)</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MMF/Cyclophosphamide/Azathioprine</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Autologous stem cell transplant<strong><u> </u></strong></span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. IV immunoglobulins:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Used as a first-line treatment, especially for acute cases of ITP or in severe cases to quickly raise the platelet count, but not as a long-term solution.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Steroids:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Common first-line treatment for ITP that can effectively increase platelet count in many patients, though many eventually relapse upon discontinuation or become steroid-dependent.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Blood transfusion:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Generally not a primary treatment for ITP since the issue is not the quantity of produced platelets but their premature destruction; transfusions might be used in acute, severe bleeding scenarios but do not address the underlying autoimmune process.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Splenectomy is often considered the best treatment option for chronic or refractory idiopathic thrombocytopenic purpura, particularly when other treatments such as steroids and IV immunoglobulins fail to maintain a safe platelet count or cause side effects that are difficult to manage.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference: ASH 2021 summary</span></span></strong></p>",
      "correct_choice_id": 44952,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "OlderNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 92140,
      "choices": [
        {
          "id": 366876,
          "text": "<p><span style=\"font-size:14.0pt;\">Pulsus Bisferiens</span></p>"
        },
        {
          "id": 366877,
          "text": "<p><span style=\"font-size:14.0pt;\">Pulsus Alternans</span></p>"
        },
        {
          "id": 366878,
          "text": "<p><span style=\"font-size:14.0pt;\">Pulsus Paradoxus</span></p>"
        },
        {
          "id": 366879,
          "text": "<p><span style=\"font-size:14.0pt;\">Pulsus Parvus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Identify the type of pulse whose mechanism is explained by the Frank-Starling Law? (INICET MAY 2025)</span></p>",
      "unique_key": "Q1552363",
      "question_audio": null,
      "question_video": null,
      "map_id": 34965190,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Pulsus Alternans</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Pulsus alternans is based on the Frank-Starling Law, which states that stroke volume and force of contractility are directly proportional to the end-diastolic volume or stretch of the myocardium at the end of diastole. Pulsus alternans presents as alternating weak and strong beating pulses and occurs in patients with severe left ventricular failure or dysfunction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_CwLi6ba.png\" width=\"816\" height=\"419\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In LV failure, the initial ventricular contraction is weak, producing a small volume pulse. Because insufficient blood is ejected, more blood accumulates in the ventricle, carrying over to the next cardiac cycle where the end-diastolic volume is very high. This activates the Frank-Starling mechanism, producing more stroke volume and stronger contraction, resulting in a strong beating pulse. This cycle continues, creating the alternating pattern. It's important to note that pulsus alternans must be regular to diagnose LV failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Pulsus Bisferiens:</strong> This occurs in hypertrophic obstructive cardiomyopathy (HOCM) or severe aortic regurgitation due to dynamic LVOT obstruction and Venturi/Bernoulli effects, producing two systolic peaks with a spike and dome appearance. It is not related to the Frank-Starling Law.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_EMjGUIW.png\" width=\"792\" height=\"484\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Pulsus Paradoxus:</strong> This represents an exaggerated fall in systolic BP (&gt;10 mmHg) during inspiration, typically seen in cardiac tamponade or status asthmaticus. It is related to ventricular interdependence and respiratory variation, not the Frank-Starling Law.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_5aOlEmo.png\" width=\"1044\" height=\"481\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Pulsus Parvus:</strong> This is a small volume pulse seen in conditions like aortic stenosis due to fixed LVOT obstruction, unrelated to the Frank-Starling mechanism.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_pCEG93A.png\" width=\"613\" height=\"367\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Pulsus alternans is the pulse type based on the Frank-Starling Law and indicates severe left ventricular failure with alternating weak and strong contractions.</span></p>",
      "correct_choice_id": 366877,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92140/Ini_Cet_May_2025_Medicine_Q_-_3new.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "InstrumentsBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92140/Ini_Cet_May_2025_Medicine_Q_-_3new.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11274,
      "choices": [
        {
          "id": 45062,
          "text": "<p><span style=\"font-size:12.0pt;\">Start IV fluids with large bore cannula</span></p>"
        },
        {
          "id": 45063,
          "text": "<p><span style=\"font-size:12.0pt;\">Needle decompression into the 5th intercostal space anterior to the midaxillary line</span></p>"
        },
        {
          "id": 45064,
          "text": "<p><span style=\"font-size:12.0pt;\">Take the patient to the ICU and intubate</span></p>"
        },
        {
          "id": 45065,
          "text": "<p><span style=\"font-size:12.0pt;\">Start positive pressure ventilation</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 20-year-old man presents to the emergency department with respiratory distress and hypotension following a trauma. He has subcutaneous emphysema and there is an absence of air entry into the right side of the lungs. What is the next best step? (NEET PG 2020)</span></p>",
      "unique_key": "Q3833110",
      "question_audio": null,
      "question_video": null,
      "map_id": 34965205,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Needle decompression into the 5th intercostal space anterior to the midaxillary line</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">History is suggestive of tension pneumothorax and hence immediate decompression is required to maintain hemodynamic stability. <strong>Definitive management involves insertion of Chest tube/Pigtail in the triangle of safety</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Start IV fluids with large bore cannula:&nbsp;</strong>While IV fluids are important in managing hypotension, they do not address the immediate life-threatening issue of tension pneumothorax and might actually exacerbate the patient's condition by increasing venous return and further compressing the heart.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Take the patient to the ICU and intubate:&nbsp;</strong>Intubation in the setting of tension pneumothorax without prior decompression can worsen the patients hemodynamic status by increasing intrathoracic pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Start positive pressure ventilation:&nbsp;</strong>Positive pressure ventilation could potentially increase the pressure in the pleural cavity, worsening the tension pneumothorax and leading to rapid hemodynamic deterioration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">In cases of tension pneumothorax, immediate needle decompression is critical to stabilize the patient and prevent further cardiovascular compromise. This emergency procedure is a life-saving intervention that precedes further definitive management like chest tube insertion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison 21/Pneumothorax/ Chap 294</strong></span></p>",
      "correct_choice_id": 45063,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73063,
      "choices": [
        {
          "id": 291217,
          "text": "<p><span style=\"font-size:16px;\">Pulmonary regurgitation</span></p>"
        },
        {
          "id": 291218,
          "text": "<p><span style=\"font-size:16px;\">Ventricular septal defect (VSD)</span></p>"
        },
        {
          "id": 291219,
          "text": "<p><span style=\"font-size:16px;\">Pulmonary stenosis</span></p>"
        },
        {
          "id": 291220,
          "text": "<p><span style=\"font-size:16px;\">Mitral Stenosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the most likely underlying condition associated with the Graham Steell murmur? (FMGE JAN 2025)</span></p>",
      "unique_key": "Q9052552",
      "question_audio": null,
      "question_video": null,
      "map_id": 34965189,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) Pulmonary regurgitation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Graham Steell murmur is a characteristic <strong>early diastolic murmur</strong> caused by <strong>pulmonary regurgitation</strong> in the setting of <strong>pulmonary hypertension</strong>. It occurs when <strong>increased pulmonary artery pressure</strong> causes dilation of the <strong>pulmonary valve ring</strong>, leading to incompetence and regurgitation. The murmur is <strong>best heard in the left second or third intercostal space</strong> and is characterized as an <strong>early diastolic, high-pitched, blowing murmur</strong> that decreases in intensity during inspiration.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Ventricular septal defect (VSD)</strong>: Produces a <strong>pansystolic murmur</strong> heard best at the <strong>left lower sternal border</strong>. A small VSD producing a loud murmur is called <strong>Maladie de Roger</strong>, not <strong>Graham Steell murmur</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Pulmonary stenosis:</strong> Produces an <strong>ejection systolic murmur</strong> best heard in the <strong>pulmonary area (left upper sternal border)</strong>. It <strong>does not produce a diastolic murmur</strong>, which is characteristic of <strong>Graham Steell murmur</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Mitral stenosis:</strong> Produces a <strong>mid-diastolic murmur</strong> best heard at the <strong>apex</strong>, with <strong>presystolic accentuation</strong>. It is associated with <strong>rheumatic heart disease</strong> and <strong>does not cause an early diastolic murmur</strong> characteristic of Graham Steell.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Graham Steell murmur is a <strong>high-pitched early diastolic murmur</strong> caused by <strong>pulmonary regurgitation</strong> in the setting of <strong>pulmonary hypertension</strong>.</span></p>",
      "correct_choice_id": 291217,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/73063/FMGE_Jan_2025_Medicine_Q_-_2_-.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "Factual",
        "FMGE"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/73063/FMGE_Jan_2025_Medicine_Q_-_2_-.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 84270,
      "choices": [
        {
          "id": 335660,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic Myeloid Leukemia (CML)</span></p>"
        },
        {
          "id": 335661,
          "text": "<p><span style=\"font-size:12.0pt;\">Polycythemia Vera (PV)</span></p>"
        },
        {
          "id": 335662,
          "text": "<p><span style=\"font-size:12.0pt;\">Essential Thrombocytosis (ET)</span></p>"
        },
        {
          "id": 335663,
          "text": "<p><span style=\"font-size:12.0pt;\">Primary Myelofibrosis (PMF)</span></p>"
        }
      ],
      "text": "<p>Which of the following myeloproliferative disorders is least likely to be associated with massive splenomegaly? (NEET PG 2016)</p>",
      "unique_key": "Q6630734",
      "question_audio": null,
      "question_video": null,
      "map_id": 34965201,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Ans. C) Essential Thrombocytosis (ET)</strong></p><p>&nbsp;</p><p>Essential thrombocytosis is the myeloproliferative disorder least likely to be associated with massive splenomegaly. While patients with ET may develop splenomegaly, it is typically mild to moderate in size. The pathophysiology of ET primarily involves excess platelet production rather than the extensive extramedullary hematopoiesis that leads to massive splenomegaly in other MPNs. ET patients can present with erythromelalgia (burning pain and redness in extremities) and thrombotic or hemorrhagic complications, but splenomegaly, when present, is generally modest. The clinical focus in ET is typically on managing thrombotic risk rather than symptoms of splenomegaly.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><strong>Option A. Chronic Myeloid Leukemia (CML)</strong>:&nbsp; Splenomegaly is a hallmark physical finding in CML, occurring in 20-70% of patients. Many patients present with moderate to massive splenomegaly that can extend well below the costal margin, sometimes filling the left side of the abdomen and causing early satiety and abdominal discomfort.</li><li><strong>Option B. Polycythemia Vera (PV)</strong>:&nbsp; PV commonly presents with splenomegaly due to expanded myeloproliferation and increased blood flow. The spleen enlargement can be substantial and is an important clinical feature of the disease, often used in monitoring disease progression.</li><li><strong>Option D. Primary Myelofibrosis (PMF)</strong>:&nbsp; PMF is characterized by progressive, often massive splenomegaly due to extramedullary hematopoiesis. The enlarged spleen in PMF frequently causes significant symptoms including abdominal pain, early satiety, and mechanical discomfort. Spleen size in PMF typically increases as the disease progresses.</li></ul><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p>Among the myeloproliferative neoplasms, essential thrombocytosis typically presents with the least pronounced splenomegaly, while PMF and CML are most strongly associated with massive splenomegaly.</p>",
      "correct_choice_id": 335662,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11596,
      "choices": [
        {
          "id": 46350,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Amphotericin B</span></span></span></p>"
        },
        {
          "id": 46351,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Griseofulvin</span></span></span></p>"
        },
        {
          "id": 46352,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dapsone</span></span></span></p>"
        },
        {
          "id": 46353,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hydroxychloroquine</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A person presents to the hospital with fever and chills. Fever profile is ordered and is found to be negative for malaria and dengue. RK-39 test is found to be positive. What is the treatment of choice?</span> (<span style=\"font-size:12.0pt\">INICET MAY 2022)</span></span></span></p>",
      "unique_key": "Q1006239",
      "question_audio": null,
      "question_video": null,
      "map_id": 34965196,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>A) Amphotericin B</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The RK-39 test is used to diagnose visceral leishmaniasis, which is also known as kala-azar. Visceral leishmaniasis is caused by the Leishmania parasite and is transmitted by the bite of infected sandflies. The test detects antibodies against the RK-39 antigen, which is a marker for this disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In India, the first-line treatment for visceral leishmaniasis is Amphotericin B. This drug is effective in treating the disease and is preferred due to its ability to clear the infection. While other treatments like sodium stibogluconate are available, Amphotericin B is the standard treatment due to its efficacy and safety profile in the Indian context.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Griseofulvin</strong>: This is an antifungal medication used to treat dermatophyte infections of the skin, hair, and nails. It is not effective against parasitic infections like leishmaniasis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Dapsone</strong>: This drug is primarily used to treat leprosy and certain types of dermatitis. It is not used for treating leishmaniasis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Hydroxychloroquine</strong>: This medication is used for the treatment of malaria, rheumatoid arthritis, and lupus erythematosus. It is not effective against leishmaniasis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The RK-39 test is used to diagnose visceral leishmaniasis, and the treatment of choice for visceral leishmaniasis in India is Amphotericin B</span></span></span></p>",
      "correct_choice_id": 46350,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11352,
      "choices": [
        {
          "id": 45374,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Intravenous salbutamol</span></span></span></p>"
        },
        {
          "id": 45375,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Intravenous nitroglycerin</span></span></span></p>"
        },
        {
          "id": 45376,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Nebulization with salbutamol</span></span></span></p>"
        },
        {
          "id": 45377,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Oxygen and antibiotics</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A hypertensive patient who is non-compliant with medication presents to you with sudden onset breathlessness. A chest X-ray was done, which is shown below. How will you manage this patient? (Neet pg 2022)</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/29/screenshot-2024-07-29-191623.jpg\" style=\"height:305px; width:400px\" /></p>",
      "unique_key": "Q1210870",
      "question_audio": null,
      "question_video": null,
      "map_id": 34965207,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B. Intravenous nitroglycerin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient presents with symptoms and signs indicative of pulmonary edema, which is evident from the chest X-ray showing interstitial edema and classic bat-wing appearance, suggestive of cardiogenic pulmonary edema. The history of hypertension and non-compliance with medication supports the diagnosis, as poorly controlled hypertension can lead to increased afterload, left ventricular failure, and subsequent pulmonary edema.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Intravenous nitroglycerin</span></strong><span style=\"font-size:12.0pt\">: Nitroglycerin is the treatment of choice in this scenario as it helps to reduce both preload and afterload by dilating veins and arteries. This leads to a reduction in pulmonary congestion and improvement in symptoms of breathlessness.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Intravenous salbutamol</span></strong><span style=\"font-size:12.0pt\">: Salbutamol is a bronchodilator used primarily in the treatment of asthma or COPD exacerbations, and primarily not used intravenously. It is not indicated for managing pulmonary edema and does not address the underlying cause of fluid accumulation in the lungs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Nebulization with salbutamol</span></strong><span style=\"font-size:12.0pt\">: Similar to intravenous salbutamol, nebulized salbutamol is used for bronchodilation in conditions like asthma or COPD. It is not effective in treating pulmonary edema and does not relieve the symptoms caused by fluid overload in the lungs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Oxygen and antibiotics</span></strong><span style=\"font-size:12.0pt\">: While oxygen might be necessary to support the patient&rsquo;s respiratory status, antibiotics are not indicated unless there is a concurrent infection, which is not suggested by the patient&rsquo;s presentation. The primary issue here is fluid overload due to heart failure, not an infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the management of cardiogenic pulmonary edema, intravenous nitroglycerin is essential to reduce preload and afterload, thereby alleviating pulmonary congestion and improving the patient&#39;s symptoms.</span></span></p>",
      "correct_choice_id": 45375,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11304,
      "choices": [
        {
          "id": 45182,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methylprednisolone</span></span></p>"
        },
        {
          "id": 45183,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Heparin</span></span></p>"
        },
        {
          "id": 45184,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Torsemide</span></span></p>"
        },
        {
          "id": 45185,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Terlipressin plus albumin</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A chronic alcoholic male patient presents with abdominal distension, reduced urine output, and pedal edema. His serum creatinine was 1.6 mg/dL. What is the next line of management in this patient?</span> <span style=\"font-size:12.0pt\">(NEET PG 2021)</span></span></span></p>",
      "unique_key": "Q3208063",
      "question_audio": null,
      "question_video": null,
      "map_id": 34965206,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D. Terlipressin plus albumin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient described has cirrhosis with signs of renal dysfunction, which suggests the possibility of hepatorenal syndrome (HRS) <strong>(Remember - HRS is the diagnosis of exclusion)</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">HRS is a type of renal failure that occurs in patients with advanced liver disease and is characterized by functional renal failure due to reduced renal blood flow.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The initial management for suspected HRS involves <strong>stopping all diuretics</strong>, as they can exacerbate renal dysfunction. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The mainstay of treatment includes the <strong>administration of albumin</strong> to expand plasma volume and <strong>vasoconstrictors </strong>to improve renal blood flow. Terlipressin is a vasoconstrictor that is commonly used in combination with albumin to manage HRS. This combination helps to improve renal function by counteracting the splanchnic vasodilation that occurs in cirrhosis, thereby increasing effective arterial blood volume and renal perfusion.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Doses &ndash; </span></strong><span style=\"font-size:12.0pt\">The prescribed dose of albumin is 1 gram per kilogram of body weight per day. The maximum dose should not exceed 100 grams per day. Albumin should be administered for at least 48 hours, equivalent to 2 days. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It&#39;s important to avoid using normal saline or lactated solutions concurrently because they contain sodium, which could be contraindicated or undesirable in the treatment circumstances requiring albumin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Methylprednisolone:</span></strong><span style=\"font-size:12.0pt\"> Methylprednisolone is a corticosteroid and is not indicated in the treatment of hepatorenal syndrome. It is used for conditions such as autoimmune hepatitis or severe alcoholic hepatitis, but it does not address the pathophysiology of HRS.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Heparin:</span></strong><span style=\"font-size:12.0pt\"> Heparin is an anticoagulant and is not appropriate in this setting due to the increased risk of bleeding in patients with cirrhosis. It is used for preventing or treating thrombotic conditions but does not play a role in managing HRS.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Torsemide:</span></strong><span style=\"font-size:12.0pt\"> Torsemide is a loop diuretic and should be discontinued in patients with HRS. Diuretics can worsen renal function in these patients by further decreasing renal perfusion and exacerbating the underlying problem of splanchnic vasodilation and renal vasoconstriction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In patients with cirrhosis and suspected hepatorenal syndrome, the appropriate management includes the use of albumin combined with vasoconstrictors like terlipressin to improve renal function and address the underlying hemodynamic changes associated with HRS.</span></span></span></p>",
      "correct_choice_id": 45185,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74877,
      "choices": [
        {
          "id": 298409,
          "text": "<p><span style=\"font-size:16px;\">HCV</span></p>"
        },
        {
          "id": 298410,
          "text": "<p><span style=\"font-size:16px;\">HAV (Hepatitis A Virus)</span></p>"
        },
        {
          "id": 298411,
          "text": "<p><span style=\"font-size:16px;\">HDV</span></p>"
        },
        {
          "id": 298412,
          "text": "<p><span style=\"font-size:16px;\">HBV</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Which of the following viruses spreads predominantly through water? (INICET NOV 2024)</span></p>",
      "unique_key": "Q1183709",
      "question_audio": null,
      "question_video": null,
      "map_id": 34965191,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) HAV (Hepatitis A Virus)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Hepatitis A virus (HAV) primarily spreads through the fecal-oral route and contaminated water. It is one of the main viral pathogens that uses water as its predominant transmission route. The virus is highly stable in water and sewage, making waterborne transmission a significant public health concern, especially in areas with poor sanitation.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. HCV (Hepatitis C Virus):</strong> Incorrect because HCV spreads predominantly through the parenteral route, particularly through needlestick injuries, blood transfusions, and surgical procedures.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. HDV (Hepatitis D Virus):</strong> Incorrect because HDV is a dependent virus that requires the presence of HBV for its replication and transmission. It cannot spread independently through water.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. HBV (Hepatitis B Virus):</strong> Incorrect because HBV primarily spreads through vertical transmission (mother to child) in developing countries like India. While sexual transmission is possible, it's relatively rare. It does not spread through water.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Hepatitis A virus spreads predominantly through the fecal-oral route and contaminated water, unlike other hepatitis viruses, which have different primary modes of transmission.</span></p>",
      "correct_choice_id": 298410,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20262,
      "choices": [
        {
          "id": 81009,
          "text": "<p><span style=\"font-size:12.0pt;\">Lamivudine</span></p>"
        },
        {
          "id": 81010,
          "text": "<p><span style=\"font-size:12.0pt;\">Tenofovir</span></p>"
        },
        {
          "id": 81011,
          "text": "<p><span style=\"font-size:12.0pt;\">Peg IFN for 52 weeks</span></p>"
        },
        {
          "id": 81012,
          "text": "<p><span style=\"font-size:12.0pt;\">Combined peg IFN with lamivudine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old male is found to be positive for HBsAg and HBeAg and is diagnosed with chronic hepatitis B. The viral load of the patient was 2 x 10^5 IU/mL and ALT is found to be doubled. What is the appropriate management? (NEET PG 2023)</span></p>",
      "unique_key": "Q4233835",
      "question_audio": null,
      "question_video": null,
      "map_id": 34965308,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Tenofovir</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient is diagnosed with chronic hepatitis B, as indicated by the positive HBsAg and HBeAg, which are markers of infection and infectivity, respectively. The viral load of 2 x 10<sup>5</sup> IU/mL and elevated ALT levels suggest active viral replication and liver inflammation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>HBsAg (Hepatitis B surface antigen)</strong>: This is a marker of infection. Its presence indicates that the person is infectious.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>HBeAg (Hepatitis B e antigen)</strong>: This is a marker of infectivity. It indicates that the virus is replicating and the patient is highly infectious.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>HBV DNA</strong>: This is a marker of viral replication. In chronic hepatitis B, a high level of HBV DNA correlates with an increased risk of complications such as cirrhosis and hepatocellular carcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The decision to start treatment in chronic hepatitis B is primarily based on the levels of HBV DNA and ALT. According to guidelines, treatment is indicated if:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">HBV DNA is more than 2000 IU/mL.</span></li><li><span style=\"font-size:12.0pt;\">ALT is elevated (more than 2 to 3 times the upper limit of normal).</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In this patient, both criteria are met.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Tenofovir</strong> is preferred for its efficacy and lower risk of resistance compared to other options like lamivudine. Tenofovir is also favored over interferon-based therapies due to better durability of response and lower side effect profile.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Lamivudine</strong>: This drug is no longer preferred due to a high risk of resistance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Peg IFN for 52 weeks</strong>: Pegylated interferon is not preferred due to less favorable response rates and a higher side effect profile compared to tenofovir.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Combined peg IFN with lamivudine</strong>: Combination therapy with pegylated interferon and lamivudine is not recommended due to increased side effects and no significant improvement in efficacy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Tenofovir is the preferred treatment for chronic hepatitis B with high viral load and elevated ALT levels due to its efficacy and lower risk of resistance.</strong></span></p>",
      "correct_choice_id": 81010,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 45442,
      "choices": [
        {
          "id": 181407,
          "text": "<p><span style=\"font-size:12.0pt;\">Cerebellopontine angle tumor</span></p>"
        },
        {
          "id": 181408,
          "text": "<p><span style=\"font-size:12.0pt;\">Maxillary Sinus Carcinoma</span></p>"
        },
        {
          "id": 181409,
          "text": "<p><span style=\"font-size:12.0pt;\">Glomus Jugulare Tumor</span></p>"
        },
        {
          "id": 181410,
          "text": "<p><span style=\"font-size:12.0pt;\">Basal Cell Carcinoma of eyelid</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Ohngren's classification and Ohngren's line are related to:(NEET PG 2017)&nbsp;</span></p>",
      "unique_key": "Q9814301",
      "question_audio": null,
      "question_video": null,
      "map_id": 34965202,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Ans. B) Maxillary Sinus Carcinoma</strong></p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>Ohngren's line and classification are specifically related to <strong>maxillary sinus carcinoma</strong>. The Ohngren's line is an imaginary line drawn from the medial canthus of the eye to the angle of the mandible, dividing the maxillary sinus into antero-inferior and postero-superior halves. This classification helps determine prognosis of maxillary sinus tumors - those occurring in the postero-superior portion have worse prognosis than those in the antero-inferior portion. This classification system is important for surgical planning and prognostication in maxillary sinus malignancies.</p><p>&nbsp;</p><p><strong>&nbsp;Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A. Cerebellopontine angle tumor</strong>: These tumors are classified using the Koos grading system based on size and compression of brainstem. Ohngren's classification is not used for these posterior fossa tumors.</p><p>&nbsp;</p><p><strong>Option C. Glomus Jugulare Tumor</strong>: These paragangliomas are classified using the Glasscock-Jackson classification or the Fisch classification systems, which are based on tumor extent and invasion. Ohngren's classification has no role in these tumors.</p><p>&nbsp;</p><p><strong>Option D. Basal Cell Carcinoma of eyelid</strong>: These skin malignancies are classified using TNM staging or histological patterns (nodular, superficial, morpheaform, etc.). Ohngren's line and classification are specifically for maxillary sinus tumors, not skin malignancies.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p>Ohngren's line divides the maxillary sinus into prognostically significant regions, with tumors posterior-superior to this line having worse prognosis due to proximity to vital structures like orbit, skull base, and pterygomaxillary fossa.</p>",
      "correct_choice_id": 181408,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16164,
      "choices": [
        {
          "id": 64616,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tuberculous meningitis</span></span></span></p>"
        },
        {
          "id": 64617,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bacterial meningitis</span></span></span></p>"
        },
        {
          "id": 64618,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Fungal meningitis</span></span></span></p>"
        },
        {
          "id": 64619,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Viral meningitis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A patient presented with a fever for 11 days with neck rigidity. A lumbar puncture was done and it showed lymphocytes predominantly, Glucose 50 mg/dL, and protein 300 mg/dL. Gram-staining was negative. CXR of the patient shows upper lobe infiltrates with hilar lymph node enlargement. What is the diagnosis? (FMGE JAN 2023)</span></span></span></p>",
      "unique_key": "Q8906401",
      "question_audio": null,
      "question_video": null,
      "map_id": 34965311,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>A) Tuberculous meningitis</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The patient presents with symptoms indicative of meningitis, including fever, neck rigidity, and abnormal cerebrospinal fluid (CSF) findings. The CSF shows lymphocyte predominance, low glucose (50 mg/dL), and high protein (300 mg/dL), which are hallmarks of tuberculous meningitis. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Additionally, the chest X-ray (CXR) revealing upper lobe infiltrates with hilar lymph node enlargement further supports the diagnosis of tuberculosis, as these are common findings in pulmonary tuberculosis that can spread to the meninges.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Bacterial meningitis:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Typically presents with <strong>neutrophil predominance in CSF</strong> rather than lymphocytes. The CSF glucose is also usually low, but the clinical and radiological findings here are not supportive of a bacterial etiology.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Fungal meningitis:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Can present similarly with lymphocytic CSF and abnormal glucose/protein levels. However, the CXR findings of upper lobe infiltrates and hilar lymph node enlargement strongly suggest tuberculosis rather than a fungal infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Viral meningitis:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Usually presents with normal glucose levels in the CSF, as viruses do not metabolize glucose. The patient&rsquo;s low CSF glucose level makes this diagnosis unlikely.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">For a patient with lymphocyte-predominant CSF, low glucose, high protein, and associated pulmonary findings such as upper lobe infiltrates with hilar lymph node enlargement, tuberculous meningitis should be highly suspected.</span></span></span></p>",
      "correct_choice_id": 64616,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11546,
      "choices": [
        {
          "id": 46150,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3 and 4</span></p>"
        },
        {
          "id": 46151,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3 and 4</span></p>"
        },
        {
          "id": 46152,
          "text": "<p><span style=\"font-size:12.0pt;\">3, 4 and 5</span></p>"
        },
        {
          "id": 46153,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4 and 5</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">During the discharge of a COVID patient who was treated with steroids and remdesivir, which of the following will you inform him about? (INICET MAY 2021)</span></p><p>&nbsp;</p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Repeat RT-PCR after 7 days of discharge</span></li><li><span style=\"font-size:12.0pt;\">Watch for the persistence of Anosmia</span></li><li><span style=\"font-size:12.0pt;\">Watch for Headache and nasal discharge</span></li><li><span style=\"font-size:12.0pt;\">Monitor glucose levels</span></li><li><span style=\"font-size:12.0pt;\">Watch for Sinusitis-like symptoms</span></li></ol>",
      "unique_key": "Q8133458",
      "question_audio": null,
      "question_video": null,
      "map_id": 34965198,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.&nbsp;C) 3, 4 and 5</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Discharging a COVID-19 patient involves providing instructions for monitoring ongoing or potential symptoms and managing side effects of treatments such as steroids and remdesivir.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>3. Watch for headache and nasal discharge:</strong> These symptoms can be part of the post-COVID syndrome or could indicate secondary infections like sinusitis, especially after treatment that might suppress the immune system.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>4. Monitor glucose levels:</strong> Steroids, often used in the treatment of severe COVID-19, can elevate blood glucose levels. Its crucial for patients, especially those with pre-existing diabetes or those who experienced high glucose levels during treatment, to monitor their levels after discharge.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>5. Watch for sinusitis-like symptoms:</strong> As with headache and nasal discharge, symptoms like those of sinusitis might suggest secondary infections, which are important to monitor given the use of immunomodulating treatments like steroids.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>1. Repeat RT-PCR after 7 days of discharge:&nbsp;</strong>Repeat RT-PCR after 7 days of discharge is not required as per updated guidelines<strong>.</strong> Repeat RT-PCR at 7 days of discharge was&nbsp;initially suggested, but later on removed from the guideline.&nbsp;</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>2. Watch for the persistence of Anosmia:&nbsp;</strong>Watch for the persistence of Anosmia is a common symptom (Anosmia can persist for weeks together) but, not matching with the options (actual answer should be 2,3,4, and 5).</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Patients recovering from COVID-19 should monitor for symptoms of headache and nasal discharge, glucose levels due to steroid use, and sinusitis-like symptoms which could indicate secondary infections like mucormycosis.</span></p>",
      "correct_choice_id": 46152,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "INICET",
        "InvestigationBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47520,
      "choices": [
        {
          "id": 189691,
          "text": "<p><span style=\"font-size:12.0pt;\">Parkinson's disease</span></p>"
        },
        {
          "id": 189692,
          "text": "<p><span style=\"font-size:12.0pt;\">Huntington's chorea</span></p>"
        },
        {
          "id": 189693,
          "text": "<p><span style=\"font-size:12.0pt;\">Friedreich's ataxia</span></p>"
        },
        {
          "id": 189694,
          "text": "<p><span style=\"font-size:12.0pt;\">Alzheimer's disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old male presents with complaints of sudden, involuntary, and uncontrollable dance-like movements. He also complains of facing difficulty with his memory. His wife says he has gotten very emotional recently. What is the most likely diagnosis?&nbsp;</span>(FMGE JULY 2023)</p>",
      "unique_key": "Q6771828",
      "question_audio": null,
      "question_video": null,
      "map_id": 34965312,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Huntington's chorea</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This patient presents with the classic triad of symptoms seen in Huntington's disease:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Hyperkinetic movements (Chorea):&nbsp;</strong>Sudden, involuntary, and uncontrollable dance-like movements are characteristic of chorea, a key feature of Huntington's disease.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Cognitive decline (Dementia):&nbsp;</strong>The patient has memory problems, which aligns with the cognitive decline seen in Huntington's disease.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Psychiatric manifestations:&nbsp;</strong>Emotional lability, as noted by the patient's wife, is common in Huntington's disease and can include depression, irritability, and other mood disturbances.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Huntington's disease is an inherited condition characterized by progressive degeneration of nerve cells in the brain, affecting movement, cognition, and behavior.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Parkinson's disease:&nbsp;</strong>This condition typically presents with hypokinetic symptoms such as bradykinesia, rigidity, and resting tremor, which do not match the hyperkinetic movements described in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Friedreich's ataxia:&nbsp;</strong>This condition usually presents in younger individuals (typically diagnosed by 15-20 years of age) with symptoms of ataxia and sensory loss. The patient in this case does not exhibit ataxia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Alzheimer's disease:&nbsp;</strong>Alzheimer's typically presents with progressive memory loss and cognitive decline in older adults (65-70+ years). It does not include hyperkinetic movements, making it an unlikely diagnosis for this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Huntington's disease is characterized by a triad of hyperkinetic movements (chorea), cognitive decline (dementia), and psychiatric symptoms, fitting the patient's presentation.</span></p>",
      "correct_choice_id": 189692,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24767,
      "choices": [
        {
          "id": 99029,
          "text": "<p><span style=\"font-size:11.0pt;\">Torsades de pointes</span></p>"
        },
        {
          "id": 99030,
          "text": "<p><span style=\"font-size:11.0pt;\">Ventricular fibrillation</span></p>"
        },
        {
          "id": 99031,
          "text": "<p><span style=\"font-size:11.0pt;\">Atrial flutter</span></p>"
        },
        {
          "id": 99032,
          "text": "<p><span style=\"font-size:11.0pt;\">Monomorphic ventricular tachycardia</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Identify the given ECG? (INICET MAY 2023)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/screenshot-2024-09-13-133825.png\" alt=\"\" width=\"300\" height=\"227\"></span></p>",
      "unique_key": "Q4433131",
      "question_audio": null,
      "question_video": null,
      "map_id": 34965194,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A)&nbsp;Torsades de pointes</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Torsades de pointes is characterized by a polymorphic ventricular tachycardia with varying QRS complex amplitudes and a twisting around the baseline.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Ventricular fibrillation:</strong> Characterized by a chaotic and irregular waveform without identifiable QRS complexes.</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Atrial flutter</strong>: Shows a sawtooth pattern of atrial activity.</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Monomorphic ventricular tachycardia:</strong> Shows uniform QRS complexes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Torsades de pointes are a type of polymorphic ventricular tachycardia with a characteristic twisting pattern.</span></p>",
      "correct_choice_id": 99029,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}